Detalhe da pesquisa
1.
Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling.
Clin Proteomics
; 21(1): 4, 2024 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38254014
2.
The KRAS-regulated kinome identifies WEE1 and ERK coinhibition as a potential therapeutic strategy in KRAS-mutant pancreatic cancer.
J Biol Chem
; 297(5): 101335, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34688654
3.
Heterogeneous Off-Target Effects of Ultra-Low Dose Dimethyl Sulfoxide (DMSO) on Targetable Signaling Events in Lung Cancer In Vitro Models.
Int J Mol Sci
; 22(6)2021 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33802212
4.
The impact of ultraviolet- and infrared-based laser microdissection technology on phosphoprotein detection in the laser microdissection-reverse phase protein array workflow.
Clin Proteomics
; 17: 9, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32165870
5.
Utilization of Proteomic Technologies for Precision Oncology Applications.
Cancer Treat Res
; 178: 171-187, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31209845
6.
An exploratory study examining how nano-liquid chromatography-mass spectrometry and phosphoproteomics can differentiate patients with advanced fibrosis and higher percentage collagen in non-alcoholic fatty liver disease.
BMC Med
; 16(1): 170, 2018 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30205811
7.
Protein network construction using reverse phase protein array data.
Methods
; 124: 89-99, 2017 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28651964
8.
Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers.
Br J Cancer
; 117(4): 494-502, 2017 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28664915
9.
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapy.
Proteomics
; 15(2-3): 365-73, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25311472
10.
A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer.
Breast Cancer Res Treat
; 147(3): 579-88, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25209003
11.
Stratification of clear cell renal cell carcinoma by signaling pathway analysis.
Expert Rev Proteomics
; 11(2): 237-49, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24575852
12.
Targeting HER2/HER3 co-mutations in metastatic breast cancer: Case reports of exceptional responders to trastuzumab and pertuzumab therapy.
Cancer Rep (Hoboken)
; 7(3): e1954, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38441358
13.
Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities.
NPJ Precis Oncol
; 8(1): 68, 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38480868
14.
Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis.
Breast Cancer Res Treat
; 137(1): 307-14, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23179600
15.
Phosphoprotein-based drug target activation mapping for precision oncology: a view to the future.
Expert Rev Proteomics
; 15(11): 851-853, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30301389
16.
Automated Classification of Lung Cancer Subtypes Using Deep Learning and CT-Scan Based Radiomic Analysis.
Bioengineering (Basel)
; 10(6)2023 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37370621
17.
Geographical Variation in Social Determinants of Female Breast Cancer Mortality Across US Counties.
JAMA Netw Open
; 6(9): e2333618, 2023 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37707814
18.
Mediator Kinase Inhibition Impedes Transcriptional Plasticity and Prevents Resistance to ERK/MAPK-Targeted Therapy in KRAS-Mutant Cancers.
Res Sq
; 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37961649
19.
AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers.
NPJ Precis Oncol
; 7(1): 18, 2023 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36797347
20.
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer.
Cancer Res
; 83(1): 141-157, 2023 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36346366